These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22378040)

  • 1. ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.
    Worzfeld T; Swiercz JM; Looso M; Straub BK; Sivaraj KK; Offermanns S
    J Clin Invest; 2012 Apr; 122(4):1296-305. PubMed ID: 22378040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
    Rivas MA; Tkach M; Beguelin W; Proietti CJ; Rosemblit C; Charreau EH; Elizalde PV; Schillaci R
    Breast Cancer Res Treat; 2010 Jul; 122(1):111-24. PubMed ID: 19760502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grb2 mediates semaphorin-4D-dependent RhoA inactivation.
    Sun T; Krishnan R; Swiercz JM
    J Cell Sci; 2012 Aug; 125(Pt 15):3557-67. PubMed ID: 22505611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.
    Swiercz JM; Kuner R; Offermanns S
    J Cell Biol; 2004 Jun; 165(6):869-80. PubMed ID: 15210733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
    Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
    Grothey A; Hashizume R; Ji H; Tubb BE; Patrick CW; Yu D; Mooney EE; McCrea PD
    Oncogene; 2000 Oct; 19(42):4864-75. PubMed ID: 11039904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion.
    Ye S; Hao X; Zhou T; Wu M; Wei J; Wang Y; Zhou L; Jiang X; Ji L; Chen Y; You L; Zhang Y; Xu G; Zhou J; Ma D; Wang S
    BMC Cancer; 2010 Nov; 10():611. PubMed ID: 21059203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.
    Rody A; Holtrich U; Gaetje R; Gehrmann M; Engels K; von Minckwitz G; Loibl S; Diallo-Danebrock R; Ruckhäberle E; Metzler D; Ahr A; Solbach C; Karn T; Kaufmann M
    Clin Cancer Res; 2007 Feb; 13(4):1115-22. PubMed ID: 17317819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plexin-B1 mutations in prostate cancer.
    Wong OG; Nitkunan T; Oinuma I; Zhou C; Blanc V; Brown RS; Bott SR; Nariculam J; Box G; Munson P; Constantinou J; Feneley MR; Klocker H; Eccles SA; Negishi M; Freeman A; Masters JR; Williamson M
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19040-5. PubMed ID: 18024597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
    Casazza A; Finisguerra V; Capparuccia L; Camperi A; Swiercz JM; Rizzolio S; Rolny C; Christensen C; Bertotti A; Sarotto I; Risio M; Trusolino L; Weitz J; Schneider M; Mazzone M; Comoglio PM; Tamagnone L
    J Clin Invest; 2010 Aug; 120(8):2684-98. PubMed ID: 20664171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plexin-B1 indirectly affects glioma invasiveness and angiogenesis by regulating the RhoA/αvβ3 signaling pathway and SRPK1.
    Chang Y; Li L; Zhang L; Guo X; Feng Z; Zhou J; Zhou S; Feng G; Han F; Huang W; Yang J; Huang F
    Tumour Biol; 2016 Aug; 37(8):11225-36. PubMed ID: 26944058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.
    Pan Q; Bao LW; Teknos TN; Merajver SD
    Cancer Res; 2006 Oct; 66(19):9379-84. PubMed ID: 17018591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility.
    Basile JR; Gavard J; Gutkind JS
    J Biol Chem; 2007 Nov; 282(48):34888-95. PubMed ID: 17855350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas.
    Ebbesen SH; Scaltriti M; Bialucha CU; Morse N; Kastenhuber ER; Wen HY; Dow LE; Baselga J; Lowe SW
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3030-5. PubMed ID: 26929372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin 4D signaling requires the recruitment of phospholipase C gamma into the plexin-B1 receptor complex.
    Swiercz JM; Worzfeld T; Offermanns S
    Mol Cell Biol; 2009 Dec; 29(23):6321-34. PubMed ID: 19805522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
    Sundqvist A; Vasilaki E; Voytyuk O; Bai Y; Morikawa M; Moustakas A; Miyazono K; Heldin CH; Ten Dijke P; van Dam H
    Oncogene; 2020 May; 39(22):4436-4449. PubMed ID: 32350443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3τ promotes breast cancer invasion and metastasis by inhibiting RhoGDIα.
    Xiao Y; Lin VY; Ke S; Lin GE; Lin FT; Lin WC
    Mol Cell Biol; 2014 Jul; 34(14):2635-49. PubMed ID: 24820414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.